Remy Biosciences focuses on foundational intellectual property for delivery of medicinal compounds directly into the bloodstream; transdermally – through the dermal (skin) layer – and sublingually – through mucosal pathways under the tongue.
​
We have 6 granted US Letters patents, and dozens of international, pending, and provisional patents in addition to protect our technology.
Our Approach
IP as an asset
Our portfolio process begins with research and extensive patent landscape surveys, all concentrated on establishing foundational rights for delivery systems, compositions of matter, machines, and formulations. Our patent landscape surveys, and our research and product development, involve select pharmaceutical active ingredients, plant extracts, psychedelic drugs, and more. All of our research and patent work is based on extensive time and effort from our science team to identify the most effective medicines for disorders ranging from pain and inflammation to mental health to sleep, women's health, and more. The patent portfolio is expected to afford Remy Biosciences freedom to operate/exploit (“FTO”) for products to be marketed and processed for making, improving, and deploying, exclusive of direct competitors.